Literature DB >> 3732372

Cross-over comparison of the fixed combination of hydrochlorothiazide and triamterene and the free combination of furosemide and triamterene in the maintenance treatment of congestive heart failure.

A J Funke Küpper, H Fintelman, M C Huige, J J Koolen, K L Liem, F A Lustermans.   

Abstract

The fixed combination of hydrochlorothiazide 25 mg and triamterene 50 mg and the free combination of furosemide 40 mg and triamterene 50 mg were compared as maintenance treatment in patients who were in a stable condition after an episode of congestive heart failure. All the patients were on digitalis. The trial was of the cross-over design. The treatment order was randomized at each centre. Each treatment lasted for 8 weeks. Of the 37 patients entering the study 30 were suitable for analysis. Both treatments were equally effective in maintaining bodyweight at the same level and in influencing symptoms. The free combination decreased the blood pressure slightly more than the fixed combination, especially the systolic pressure. One-third of the patients were hypertensive at the outset (diastolic pressure greater than 95 mm Hg) and in them the effects of the two treatments were not significantly different. The majority of the patients (80%) preferred treatment with the fixed combination because it caused slower and less frequent micturition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732372     DOI: 10.1007/bf00541540

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  2 in total

1.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

2.  The crossover experiment for clinical trials.

Authors:  B W Brown
Journal:  Biometrics       Date:  1980-03       Impact factor: 2.571

  2 in total
  3 in total

Review 1.  READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trials.

Authors:  Tobias Täger; Hanna Fröhlich; Mirjam Seiz; Hugo A Katus; Lutz Frankenstein
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 2.  Optimising management of patients with advanced heart failure: the importance of preventing progression.

Authors:  B Stanek
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

Review 3.  Decongestion: Diuretics and other therapies for hospitalized heart failure.

Authors:  Ali Vazir; Martin R Cowie
Journal:  Indian Heart J       Date:  2015-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.